Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Nakhonpathom, Thailand.
Indian J Med Res. 2011 Oct;134(4):498-506.
In Southeast Asia α-thalassaemia, β-thalassaemia, haemoglobin (Hb) E and Hb Constant Spring (CS) are prevalent. The abnormal genes in different combinations lead to over 60 different thalassaemia syndromes, making Southeast Asia the locality with the most complex thalassaemia genotypes. The four major thalassaemic diseases are Hb Bart's hydrops fetalis (homozygous α-thalassaemia 1), homozygous β-thalassaemia, β-thalassaemia/Hb E and Hb H diseases. α-Thalassaemia, most often, occurs from gene deletions whereas point mutations and small deletions or insertions in the β-globin gene sequence are the major molecular defects responsible for most β-thalassaemias. Clinical manifestations of α-thalassaemia range from asymptomatic cases with normal findings to the totally lethal Hb Bart's hydrops fetalis syndrome. Homozygosity of β-thalassaemia results in a severe thalassaemic disease while the patients with compound heterozygosity, β-thalassaemia/Hb E, present variable severity of anaemia, and some can be as severe as homozygous β-thalassaemia. Concomitant inheritance of α-thalassaemia and increased production of Hb F are responsible for mild clinical phenotypes in some patients. However, there are still some unknown factors that can modulate disease severity in both α- and β-thalassaemias. Therefore, it is possible to set a strategy for prevention and control of thalassaemia, which includes population screening for heterozygotes, genetic counselling and foetal diagnosis with selective abortion of affected pregnancies.
在东南亚,α-地中海贫血、β-地中海贫血、血红蛋白(Hb)E 和 Hb Constant Spring(CS)很常见。不同组合的异常基因导致了 60 多种不同的地中海贫血综合征,使东南亚成为地中海贫血基因型最复杂的地区。四种主要的地中海贫血疾病是 Hb Bart's 胎儿水肿(纯合子α-地中海贫血 1)、纯合子β-地中海贫血、β-地中海贫血/Hb E 和 Hb H 疾病。α-地中海贫血通常由基因缺失引起,而点突变和β-珠蛋白基因序列中的小缺失或插入是导致大多数β-地中海贫血的主要分子缺陷。α-地中海贫血的临床表现从无症状的正常发现到完全致命的 Hb Bart's 胎儿水肿综合征不等。β-地中海贫血的纯合子导致严重的地中海贫血疾病,而复合杂合子,β-地中海贫血/Hb E 的患者则表现出不同程度的贫血,有些患者的严重程度与纯合子β-地中海贫血相当。α-地中海贫血的同时遗传和 Hb F 的增加产量导致一些患者出现轻度临床表型。然而,仍有一些未知因素可以调节α-和β-地中海贫血的疾病严重程度。因此,可以制定地中海贫血的预防和控制策略,包括对杂合子进行人群筛查、遗传咨询和选择性终止受影响妊娠的胎儿诊断。